Title: Use of Pre and Probiotics in Broilers
1 Use of Pre- and Probiotics in Broilers
- Todd J. Applegate J.A. PattersonPurdue
UniversityV. Klose University of Natural
Resources Applied Life Sciences (BOKU), Vienna,
Austria
2"The right to search for truth implies also a
duty one must notconceal any part of what one
has recognized to be true." Albert
Einstein, 1879-1955
3"The right to search for truth implies also a
duty one must notconceal any part of what one
has recognized to be true." Albert
Einstein, 1879-1955
4Definition of Probiotics
- microbial food supplements that beneficially
affect the host by improving its intestinal
microbial balance. Gibson and Roberfroid
(1995) - live microorganisms which when administered in
adequate amounts confer a health benefit on the
host. WHO/FAO (2001) - food or food supplements containing defined
microorganisms in sufficient numbers to reach the
gut in viable status resulting in positive health
effects after consumption. Wassenaar and Klein
(2008)
5Definition of Probiotics
- microbial food supplements that beneficially
affect the host by improving its intestinal
microbial balance. Gibson and Roberfroid
(1995) - live microorganisms which when administered in
adequate amounts confer a health benefit on the
host. WHO/FAO (2001) - food or food supplements containing defined
microorganisms in sufficient numbers to reach the
gut in viable status resulting in positive health
effects after consumption. Wassenaar and Klein
(2008)
6Competitive Exclusion-Concept (Nurmi and
Rantala, Nature 241, 1973)
Feeding of adult microflora (intestinal contents
/ feces) protects newly hatched chicks from
Salmonella infections via establishment of an
improved intestinal microflora
7- Undefined CE products from European perspective
- Lack of characterization
- Pathogenic subspecies
- No information about antibiotic resistance genes
- Lack of quality control measures
- No approval in EU
8Probiotics - Registration
- US GRAS system (established history of safe use
(before 1958) or positive safety evaluation - EU Qualified Presumption of Safety (QPS)
- Non-QPS strains full safety assessment
- VERSUS Competitive Exclusion (CE) products
- Still allowed in certain countries
9Safety testing for non-QPS (EU)
- 90 day oral toxicity (100 rats)
- Acute dermal irritation / corrosion (6 rabbits)
- Skin sensitization (15 guinea pigs)
- Mouse Micronucleus Assay (60 mice)
- Ames test for genotoxicity (in vitro)
- Chromosome Aberration (in vitro)
- Tolerance test in target species (100X dose)
- Lack of virulence determinants
- Minimum inhibitory concentration across spectrum
of antibiotics (with plausible genetic basis of
resistance determined)
10QPS System Result.
- Individual registration of each strain
- Predominance of single strain products (only 12
strains approved to date) - Bacillus cereus
- B. licheniformis
- B. subtilis
- Enterococcus faecium
- Pediococcus acidalactici
- Lactobacillus farciminis
- L. rhamnosus
- L. casei
- L. plantarum
- Streptococcus infantarius
- Saccharomyces cerevisiae
11Strain Selection (Dunne et al., 1999)
- Be of origin to the animal.
- Demonstrate non-pathogenic behavior.
- Exhibit resistance to technological processes
(i.e. viability and activity in delivery
vehicles). - Prove resistant to gastric acid and bile.
- Adhere to gut epithelial tissue.
- Persist, albeit for short periods, in the GIT
- Produce antimicrobial substances.
- Modulate immune responses.
- Have the ability to influence metabolic
activities (e.g., cholesterol assimilation,
lactase activity, vitamin production).
12? different mechanisms?
13Broiler Microflora
Lu et al, 2003
16S rDNA library
14Broiler Microflora
Lu et al, 2003
16S rDNA library
15Broiler Ileal bacteria(16SrDNA clone libraires
T-RFLP)
Lu et al., 2008
16In vitro Screening
- Isolation and characterization of bacteria
- Evaluation and selection of strain able to
exclude pathogens - Risk assessment investigation for registration
- pH reduction capabilities / bacteriocin production
17Inhibition results
18Inhibition results of CE5-strains
5 strain mix
19Adhesion of probiotics to intestinal cells in
vitro
- to examine isolated strains from chicken with
regard to their adhesion ability to Caco-2 and
HT-29 intestinal cells in vitro.
HT-29
Caco-2
20Adhesion to intestinal cells
21Reduction of pH
22Reduction of pH
Result Improved reduction of pH using a
combination of selected CE-strains (synergistic)
23Where do probiotic strains go?Molecular
tracking
- Plasmid encoded fluorescent protein gene placed
w/ inducible promoter (Geoffroy et al., 2000) - DNA label
- Silent Mutations (w/o affecting AA sequence of
gene product) (Malinen et al., 2001) - .... Great for research (wild type vs.
modified).not so great registering / selling a
GMO in certain markets - Plasmid profiling, ribotyping, random amplified
polymorphic DNA, DNA fingerprinting via PFGE - . Limited in complex microbial environments
(i.e. the GUT)
24Where do probiotic strains go?Molecular
tracking
- Genome-based tracking techniques can ID specific
sequences among highly similar genomes - Suppression subtractive hybridization (SSH)
- Differential display PCR
- Representational difference analysis
- Microarray
25Necrotic enteritis
Normal
Normal healthy intestinal villi
Enteritis shortened blunted villiless surface
area but what else
26GIT Responses to Insult
- a) Peristalsis increases
- b) Epithelial turnover (changes to
proliferation, apoptosis, differentiation of
cells towards immune response) c) Mucin
productiond) Paracellular barrier Tight
Junctions (osmotic diarrhea)e) Facilitation of
commensal flora through secretionsf) Unfamiliar
response Acute phase response - g) Acquired response
27Probiotic (multi-strain) Influence on Immunity
(Dalloul Lillehoj, 2005)
- During Emeria acervulina challenge
- Improved serum and intestinal markers if immunity
- 4X fewer oocysts shed
- Improvements to intestinal structure
28Multistrain Probiotic Intestinal measures (7
days after coccidial vaccine challenge)
Teichmann, Applegate, Reisinger, Mohnl,
unpublished
29Why do we need to know where the strains go?
30Lactobacillus plantarum Influence on Human
Duodenal Mucosa RNA
Upregulated
van Baarlen et al., 2009
31Lactobacillus plantarum Influence on Human
Duodenal Mucosa RNA
Upregulated
Upregulated
van Baarlen et al., 2009
32Lactobacillus plantarum Influence on Human
Duodenal Mucosa RNA
Upregulated
Upregulated
van Baarlen et al., 2009
33(No Transcript)
34Cost of Immunity Acute Phase Response (feed
intake 14-22 days)
a
abP lt 0.05
b
b
b
Jiang et al., 2009
35Cost of Immunity Acute Phase Response (feed
intake)
a
abcP lt 0.05
ab
a
b
b
c
c
b
a
b
b
b
Jiang et al., 2009
36Cost of Immunity Acute Phase Response (Weight
gain)
P 0.001
Jiang et al., 2009
37Cost of Immunity Acute Phase Response (Weight
gain)
P 0.068
P 0.001
Probiotic supplementation reduced the cost of
immune response by 40
Jiang et al., 2009
38Immunological Response
- Quantity Quality
- Holistic Effect on Bird
Feed intake vs. Control
39 Prebiotics
- Non-digestible food ingredients that
beneficially affect the host by selectively
stimulating the growth and/or activity of
intestinal bacteria that may improve host health - Synbiotics
- Combinations of prebiotics and probiotics
- Gibson and Roberfroid, 1995
40 Prebiotics
- Fructooligosaccharides
- Oligofructose
- Inulin
- STOC
- Sucrose thermal
- oligosaccharide caramel
- GOS
- Stachyose, Raffinose
- TOS
- Transgalactooligosaccharides
- Lactulose
- Lactitol
- Lactose
- ? Galactooligosaccharides
- Xylooligosaccharides
41Do pre- /or pro-biotics affect pathogens???
- Approach 1
- Change in a) presence / absence b)
concentration - Approach 2
- Change in virulence (e.g. hilA from Salmonella)
- Approach 3
- Translocation (e.g. Salmonella in spleen)
42Ileal Loop/Salmonella Attachment Assay
1 h, 37 C 20 CO2
Ileal segmenta) flushed, b) homogenized, c)
serially diluted d) enumerated for S.
typhimurium on LB-kan
Kanamycin-resistant S. typhimurium
10-cm section of ileum
10-cm section of ileum
43Influence of diet on ileal susceptibility to
Salmonella Enteriditis attachment
Burkholder, Patterson Applegate, unpublished
44Conclusions
- Knowns
- Positively influence performance (not in all
cases but neither do AGPs) - Modulate Immunity
- Suppression of pathogens (broad array of
capability(ies)
- Unknowns
- Where do they go in the GIT ( what life stage
are they) - Holistic view of immune modulation
- Synergy in vivo
- Limitations
- Tracking tools
- Registration hurdles
45What Should be done with Present Days
Information?
- Probiotics today.are NOT a commodity (i.e.
products are unique) - Specific Pathogen Exclusion on farm (e.g.
Salmonella)..but what happens when put in
contaminated crates to go to plant? - Immunological enhancement
- Need to answer physiological questions
- What life stage
- Where are they living
- What interaction occurs with host what is
hosts response